Theraclion SA Sustainability Reports
Theraclion S.A. develops, manufactures, and markets innovative echotherapy medical devices that use high-intensity focused ultrasound (HIFU) technology. Its products include Sonovein for non-invasive varicose vein therapy and Echopulse for non-invasive treatment of breast fibroadenomas and thyroid nodules.
Sector: Manufacturing
Country: France
Exchange: Euronext Paris
LEI: 9695007X7HA7A1GCYD29
FIGI: BBG006BRBRK0
1 reports from 2022 to 2022
